SCHEMBL6154248

SCHEMBL6154248

[NH]c1cccc(SCCCc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
MAOB P27338 4/20 0.44
MAOA P21397 3/20 0.44
NOS1 P29475 2/20 0.44
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.41
AR P10275 1/20 0.40
MCL1 Q07820 1/20 0.40
BCL2A1 Q16548 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
CA2 P00918 2/20 0.38
IDO1 P14902 1/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1932895 0.82 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3390318 0.80 MAOA (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6154261 0.80 MAOB (0.55) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6477384 0.76 APEX1 (0.58) CYP1A2CYP2C9ALDH1A1MCL1BCL2A1
SCHEMBL6662548 0.76 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1710646 0.76 MAOB (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6155200 0.76 MAOA (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL23169435 0.76 BACE1 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Isothiocyanate SCHEMBL6153770 0.76 CYP1A2 (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1710556 0.73 HTR6 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP CYP1A2 4398/4885CYP3A4 4650/4885CYP2D6 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.